BioCardia, Inc.BCDANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank53
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-7.51M
↑ 20% vs avg
Percentile
P53
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
$-9.41M
Historical baseline
PeriodValueYoY Change
TTM$-7.51M+6.4%
2024$-8.03M+19.6%
2023$-9.99M+6.1%
2022$-10.63M-1.4%
2021$-10.48M+15.4%
2020$-12.39M-29.2%
2019$-9.59M+13.9%
2018$-11.13M-26.4%
2017$-8.81M-59.5%
2016$-5.52M-